April 3, 2026

Verastem, Inc. (VSTM) Stock Analysis: A Biotech with Nearly 191% Upside Potential and Strong Buy Ratings

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company specializing in oncology, stands out in the biotechnology sector with a remarkable potential upside of 190.85%. This development-stage company,..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unpacking a 117% Potential Upside for Biotech Investors

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a dynamic player in the biotech arena, is capturing investor attention with a remarkable potential upside of 117.29%, according to recent..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unpacking an 88.10% Potential Upside

Investors seeking opportunities in the healthcare sector might find Keros Therapeutics, Inc. (NASDAQ: KROS) an intriguing proposition. As a clinical-stage biopharmaceutical company, Keros focuses on developing..

Autolus Therapeutics plc (AUTL) Stock Analysis: Exploring a Potential 523.40% Upside in Biotech Innovations

Autolus Therapeutics plc (NASDAQ: AUTL), a United Kingdom-based clinical-stage biopharmaceutical company, is capturing investor attention with its ambitious pipeline in T cell therapies aimed at combating..

Butterfly Network, Inc. (BFLY) Stock Analysis: Strong Buy Ratings and 35% Upside Potential

Butterfly Network, Inc. (NYSE: BFLY) is making waves in the healthcare sector, specifically within the medical devices industry, with its innovative approach to ultrasound imaging solutions...

Altimmune, Inc. (ALT) Stock Analysis: Exploring the 438.92% Potential Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT), a promising player within the biotechnology sector, is capturing investor interest with its potential for substantial stock price appreciation. As a late..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating the 70% Upside Potential

Individual investors eyeing opportunities in the healthcare sector may want to consider Standard BioTools Inc. (NASDAQ: LAB), a company operating within the medical devices industry. With..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a Potential 138.80% Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is making waves in the biotechnology sector, catching the eyes of investors with its ambitious genetic therapy programs aimed at addressing..

CeriBell, Inc. (CBLL) Stock Analysis: Unpacking the 50% Potential Upside for Innovative Medical Device Investors

CeriBell, Inc. (CBLL), a medical technology company situated at the forefront of the healthcare sector, is capturing the attention of investors with its robust growth prospects..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Evaluating a 156% Potential Upside in Biotechnology

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is gaining significant attention in the biotechnology sector, thanks to its promising pipeline and cutting-edge technology. Headquartered in Watertown, Massachusetts, Tectonic..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech Contender with a 55% Upside Potential

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing investor attention with its innovative approach in the biotechnology sector, specifically focusing on central nervous system (CNS) disorders. With..

iRadimed Corporation (IRMD) Stock Analysis: Healthcare Innovator Eyes 24.7% Upside

iRadimed Corporation (NASDAQ: IRMD), a leading name in the healthcare sector’s medical devices industry, is making waves with its impressive performance metrics and a notable potential..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Growth Potential in the Senior Care Sector

Sonida Senior Living, Inc. (SNDA) is emerging as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Navigating Growth Potential in the Biotech Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a burgeoning entity in the biotechnology landscape, is making waves with its commitment to developing innovative treatments for both childhood..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a 738% Potential Upside in Biotech

As the healthcare sector continues to be a fertile ground for innovation and potential breakthroughs, Humacyte, Inc. (NASDAQ: HUMA) stands out as a compelling player in..

Zenas BioPharma, Inc. (ZBIO): Investor Outlook on a Potential 95.71% Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a burgeoning name in the biotechnology sector, is capturing investor attention with its compelling growth potential and innovative pipeline. Despite a..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 257% Upside in the Healthcare Sector

As individual investors seek opportunities for substantial returns in the healthcare sector, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents a compelling case with a potential upside of..

Abivax SA (ABVX) Stock Analysis: A Promising 31% Upside in the Biotech Sector

Abivax SA (ABVX), a clinical-stage biotechnology company based in Paris, France, is capturing the attention of investors with its ambitious focus on developing groundbreaking therapeutics for..

Geron Corporation (GERN) Stock Analysis: Exploring a Potential 104% Upside in Biotech Innovation

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company deeply rooted in oncology therapeutics, is capturing investor attention with its promising pipeline and a notable potential upside of..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Assessing the Potential 193% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI) has emerged as a notable player in the medical devices sector, primarily focusing on innovative solutions for correcting bunion deformities...

Search

Funds

April 3, 2026

Search

Funds

April 3, 2026

FTSE 100

Funds